{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:47:40Z","timestamp":1780440460203,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.cld.2015.10.004","type":"journal-article","created":{"date-parts":[[2016,2,20]],"date-time":"2016-02-20T02:20:54Z","timestamp":1455934854000},"page":"387-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Extrahepatic Complications of Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"20","author":[{"given":"Kristina R.","family":"Chacko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"Soderberg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2015.10.004_bib6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.23135","article-title":"Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels","volume":"50","author":"Haring","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.atherosclerosis.2008.12.012","article-title":"Elevated alanine aminotransferase levels predict mortality from cardiovascular","volume":"205","author":"Yun","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cld.2015.10.004_bib8","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1053\/j.gastro.2008.09.018","article-title":"Aminotransferase levels and 20-year risk of metabolic syndrome","volume":"135","author":"Goessling","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.10.004_bib10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2015.10.004_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.10.004_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2008.06.012","article-title":"Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review","volume":"49","author":"Sookoian","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.10.004_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","article-title":"Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome","volume":"204","author":"Kim","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cld.2015.10.004_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2015.04.009","article-title":"Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men","volume":"240","author":"Ozturk","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cld.2015.10.004_bib16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2015.10.004_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","article-title":"Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study","volume":"235","author":"VanWagner","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2015.10.004_bib20","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.cgh.2015.01.027","article-title":"Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis","volume":"13","author":"Arulanandan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.10.004_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2014.11.030","article-title":"Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease","volume":"62","author":"Petta","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.10.004_bib22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc06-2247","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cld.2015.10.004_bib23","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib26","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","article-title":"Obesity, inflammation, and insulin resistance","volume":"132","author":"Shoelson","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2015.10.004_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cld.2015.10.004_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4093\/dmj.2015.39.1.10","article-title":"Hepatokines as a link between obesity and cardiovascular diseases","volume":"39","author":"Yoo","year":"2015","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.cld.2015.10.004_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/dc11-1853","article-title":"Combined influence of insulin resistance, overweight\/obesity, and fatty liver as risk factors for type 2 diabetes","volume":"35","author":"Sung","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/dc08-1870","article-title":"Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis","volume":"32","author":"Fraser","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.arcmed.2013.01.007","article-title":"Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study","volume":"44","author":"Choi","year":"2013","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib34","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.4238\/2015.April.10.1","article-title":"Role of APN and TNF-\u03b1 in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease","volume":"14","author":"Lin","year":"2015","journal-title":"Genet Mol Res"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib36","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/hep.25539","article-title":"Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease","volume":"55","author":"Lomonaco","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1159\/000343885","article-title":"Association between non-alcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988\u20131994","volume":"36","author":"Sirota","year":"2012","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","article-title":"Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men","volume":"57","author":"Chang","year":"2008","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1478-3231.2011.02623.x","article-title":"Impaired renal function in morbid obese patients","volume":"32","author":"Machado","year":"2012","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.cld.2015.10.004_bib41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.metabol.2009.12.012","article-title":"Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis","volume":"59","author":"Yilmaz","year":"2010","journal-title":"Metab Clin Exp"},{"issue":"12","key":"10.1016\/j.cld.2015.10.004_bib42","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.cld.2015.10.004_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib44","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"37","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.cld.2015.10.004_bib45","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2007101155","article-title":"Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease","volume":"19","author":"Targher","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1681\/ASN.2009080820","article-title":"Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK","volume":"21","author":"Ix","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"32","key":"10.1016\/j.cld.2015.10.004_bib47","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.2174\/092986712803833254","article-title":"Adiponectin: key player in the adipose tissue-liver crosstalk","volume":"19","author":"Moschen","year":"2012","journal-title":"Curr Med Chem"},{"issue":"7","key":"10.1016\/j.cld.2015.10.004_bib48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.amjcard.2005.05.052","article-title":"Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension","volume":"96","author":"Tsioufis","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.cld.2015.10.004_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib50","first-page":"1645","article-title":"Adiponectin regulates albuminuria and podocyte function in mice","volume":"118","author":"Sharma","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib51","doi-asserted-by":"crossref","first-page":"e0125261","DOI":"10.1371\/journal.pone.0125261","article-title":"BMI and lifetime changes in BMI and cancer mortality risk","volume":"10","author":"Taghizadeh","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cld.2015.10.004_bib52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/hepr.12407","article-title":"Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease","volume":"45","author":"Seko","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2015.10.004_bib53","unstructured":"Haggar FA. 2009."},{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib54","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2011.237974","article-title":"High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib55","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s11033-014-3157-y","article-title":"Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study","volume":"41","author":"Lin","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1756283X11402118","article-title":"Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease","volume":"4","author":"Touzin","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2015.10.004_bib57","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/codi.12172","article-title":"Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy","volume":"15","author":"Huang","year":"2013","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.cld.2015.10.004_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1440-1746.2011.06816.x","article-title":"Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study","volume":"27","author":"Lee","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib59","first-page":"2211","article-title":"Association of liver steatosis with colorectal cancer and adenoma in patients with metabolic syndrome","volume":"35","author":"Fiori","year":"2015","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib60","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/j.gastro.2012.06.001","article-title":"United States Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer","volume":"143","author":"Lieberman","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib61","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-13-0296","article-title":"Non-alcoholic fatty liver disease in common endocrine disorders","volume":"169","author":"Hazlehurst","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0029-1202774","article-title":"Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate","volume":"118","author":"Haider","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/uog.10084","article-title":"Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome","volume":"39","author":"Zueff","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"26","key":"10.1016\/j.cld.2015.10.004_bib64","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.14310\/horm.2002.1236","article-title":"In overweight\/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls","volume":"8","author":"Economou","year":"2009","journal-title":"Hormones"},{"issue":"10","key":"10.1016\/j.cld.2015.10.004_bib66","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.cld.2015.10.004_bib67","first-page":"488","article-title":"Metabolic syndrome prevalence in subclinic and overt hypothyroid patients and the relation among metabolic syndrome parameters","volume":"34","author":"Erdogan","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.cld.2015.10.004_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"issue":"25","key":"10.1016\/j.cld.2015.10.004_bib69","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.3748\/wjg.v20.i25.8102","article-title":"Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review","volume":"20","author":"Eshraghian","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2015.10.004_bib70","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2006.0235","article-title":"Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)","volume":"17","author":"Aoki","year":"2007","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.cld.2015.10.004_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044136","article-title":"Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.cld.2015.10.004_bib73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","article-title":"Bone disorders in chronic liver disease","volume":"46","author":"Collier","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","article-title":"Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women","volume":"42","author":"Moon","year":"2012","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib75","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","article-title":"Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib76","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2015.10.004_bib77","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s10620-015-3650-8","article-title":"Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology","volume":"60","author":"Corey","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"issue":"1","key":"10.1016\/j.cld.2015.10.004_bib79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0032-1306426","article-title":"Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms","volume":"32","author":"Musso","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2015.10.004_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/815721","article-title":"OSAS-related inflammatory mechanisms of liver injury in nonalcoholic fatty liver disease","author":"Paschetta","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.cld.2015.10.004_bib81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12072-015-9615-3","article-title":"Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center","volume":"9","author":"Agrawal","year":"2015","journal-title":"Hepatol Int"},{"issue":"11","key":"10.1016\/j.cld.2015.10.004_bib82","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jclinpath-2012-201302","article-title":"Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis","volume":"66","author":"Reynolds","year":"2013","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.cld.2015.10.004_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency\u2013an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cld.2015.10.004_bib84","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2015.10.004_bib85","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2014.06.022","article-title":"Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency","volume":"61","author":"Valayannopoulos","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2015.10.004_bib86","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.26289","article-title":"Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease","volume":"58","author":"Balwani","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.10.004_bib87","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T16:24:06Z","timestamp":1567614246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1089326115001014"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.10.004","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrahepatic Complications of Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}